Everest Medicines' (HKG:1952) honorary chairman and substantial shareholder, Wei Fu, increased his stake in the company, according to a Friday Hong Kong bourse filing.
The 660,000 shares were acquired from the open market on May 14 for about HK$20.7 million at an average price of about HK$31.25 apiece.